Recognition, Assessment and Treatment
National Clinical Guideline Number 159
Learning objectives
• Promote respect and dignity for people with self-harm/suicide.
• Know the common presentations of self-harm/suicide.
• Know the principles of assessment of self-harm/suicide.
• Know the management principles of self-harm/suicide.
• Perform an assessment for self-...harm/suicide.
• Assess and manage co-morbid physical health conditions
• Assess and manage emergency presentations of self-harm/suicide.
• Provide psychosocial interventions to persons with self-harm/suicide.
• Provide follow-up sessions for people with self-harm/suicide.
• Refer to mental health specialists and links to outside agencies
more
DEM supporting material
• Person stories
• Role plays
• Case scenarios
• Treatment planning handouts
• Treatment planning suggestions
• Multiple choice questions
• Video link
Activity 3: mhGAP DEM module – assessment
Session Outline
•General Principles
•Essentials of mental health care and clinical practice: Assessments
•Essentials of mental health care and clinical practice: Management
•Essentials o...f mental health care and clinical practice: Follow-up
•Reviews
more
Clinical management standard operating procedures.
Ebola virus disease (EVD) is a life-threatening multisystem illness associated with fever and gastrointestinal (GI) symptoms that frequently leads to hypovolaemia, metabolic acidosis, hypoglycaemia, and multi-organ failure. The prolonged 2013–201...6 EVD outbreak in West Africa allowed for an evolution of care such that by outbreak end many patients received individualized and optimized supportive care (oSoC), including volume resuscitation, symptom control, laboratory and bedside monitoring of glucose, electrolyte levels and organ dysfunction, as well as rapid detection and treatment of co-infections, potentially contributing to the downward trend in the case fatality rate (CFR).
This guidance should serve as a foundation for oSoC that should be followed to ensure both the best possible chance for survival and allow for reliable comparison of investigational therapeutic interventions as part of a randomized controlled trial. This guideline provides recommendations for the management of adults and children.
more
Цель этого документа – повысить уровень осознания актуальности приоритетных направлений научных исследований по проблеме ТБ/ВИЧ (то есть по тем направлениям, кот...орые требуют срочного финансирования и внимания ученых), содействовать координации информационно-пропагандистской работы и стимулировать финансирование научных изысканий. Поставленная задача заключается в наращивании темпов осуществления высококачественных и интегрированных вмешательства по борьбе с ТБ/ВИЧ в условиях ограниченных ресурсов. В документе дается описание пересмотренной повестки дня по приоритетным научным вопросам, в основе которой лежат недавно полученные фактические данные по шести ключевым проблемам коинфекции ТБ и ВИЧ.
more
Esta guía está enfocada en emitir recomendaciones para el diagnóstico y el tratamiento de la enfermedad de Chagas, como infección por Trypanosoma cruzi, agente protozoario de una parasitosis sistémica. Metodología: La presente guía de práctica clínica fue confeccionada siguiendo los método...s de elaboración de guías de la OMS (5). De forma general, se conformó un grupo desarrollador multidisciplinario compuesto por expertos temáticos, epidemiólogos, metodólogos y usuarios. Dado que no se identificaron guías susceptibles de ser adaptadas, la guía se desarrolló de novo.
Updated guideline, June 2019
more
Toolkit
HIV Treatment and Care
The aim of the operational framework is to ensure 1) accurate collection, handling, shipment and storage of specimens collected in countries implementing HIV drug resistance surveillance; and 2) the availability of quality-assured HIV genotyping laboratory services producing comparable and reliable ...results at the national, regional and global levels.
This publication updates the WHO HIVResNet HIV drug resistance laboratory operational framework published in 2017 and reflects technical and strategic developments over the past three years.
more
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr...am-negative bacteria, such as Klebsiella pneumoniae and Escherichia coli, can cause severe and often deadly infections that pose a particular threat for people with weak or not yet fully developed immune systems, including newborns, ageing populations, people undergoing surgery and cancer treatment.
The report highlights a worrying gap in activity against the highly resistant NDM-1 (New Delhi metallo-beta-lactamase 1), with only three antibiotics in the pipeline. NDM-1 makes bacteria resistant to a broad range of antibiotics, including those from the carbapenem family, which today are the last line of defence against antibiotic-resistant bacterial infections.
more
30th World AIDS Day Report
STAR Initiative, Unitaid and World Health Organization December 2018
Participant Manual
October 2009
Using the WHO model list of essential medicines to update a national essential medicines list
Since 1977, WHO has been working with countries to design the package of essential medicines as an integral component of treatment within the continuum of care, developing and disseminating the Model List ...of Essential Medicines (Model List). WHO is committed to supporting Member States in sharing best practices in selecting
essential medicines, and in developing processes for the selection of medicines for national essential medicines lists (national EMLs, or NEMLs) consistent with the evidence-based methods used for updating the WHO Model List.
more
This leaflet provides support and advice for adults who are recovering from COVID-19. It can be used by individuals after hospitalization from the illness and those in the community who did not need hospitalization. The leaflet can complement care received from ...dbox">health care professionals. This is the second edition of the leaflet that was originally published mid 2020 that includes updates to sections and new topics, encompassing what we have learnt about the condition and recovery in the last year. The leaflet was written by rehabilitation professionals in consultation with people recovering from COVID-19. Although references are not shown for ease of reading, the advice is evidence-based. There is still much we don’t know about post-COVID-19 recovery, and evidence is fast emerging.
Available in different languages
more
Os tomadores de decisão precisam fazer escolhas difíceis para garantir que a COVID-19 e outros problemas urgentes, e contínuos, de saúde pública sejam abordados, minimizando os riscos para os profissionais de saúde e comunidades. Conforme estabelecido na Conferência Mundial de Astana sobre At...enção Primária à Saúde de 2018, o nível comunitário é uma plataforma integral para a atenção primária à saúde, essencial para a prestação de serviços e funções essenciais de saúde pública e para o envolvimento e a capacitação das comunidades em relação à sua saúde. Esta plataforma comunitária, com suas capacidades distintas para prestação de serviços de saúde e engajamento social, tem um papel fundamental a desempenhar na resposta à COVID-19, sendo essencial para o atendimento das contínuas necessidades de saúde das pessoas, especialmente as mais vulneráveis.
more
Integrated Management of Acute Malnutrition National Guidelines
9 September 2020
In a snapshot, fair allocation of vaccines will occur in the following way:
An initial proportional allocation of doses to countries until all countries reach enough quantities to cover 20% of their population
This document is also available in Arabic | Chinese | French | R...ussian | Spanish | Portuguese
A follow-up phase to expand coverage to other populations. If severe supply constraints persist, a weighted allocation approach would be adopted, taking account of a country’s COVID threat and vulnerability.
The document is a final working document and may be adjusted in the future as new information about the vaccines and the epidemiology of COVID-19 becomes available.
more
Technical Meeting Report, 14-15 July 2020, Geneva
WHO-2019-nCoV-genomic_sequencing